Commentary
Video
Factors Influencing Personalized Parkinson Disease Care
Author(s):
Stuart H. Isaacson, MD, FAAN, speaks to the current understanding of genetics and other factors in the individualization of care for patients with Parkinson disease.
Video Player is loading.
Editor's note: Because of an unfortunately unaddressable issue, the audio for this episode may be slightly distorted at times. Please see the transcript below for clarity.
Transcript to come.
Related Videos
Advancing MS Care Through Early Intervention and Deeper CNS Insights: Jack P. Antel, MD
Second-Line Treatments for CIDP
Evaluating Efficacy and Individualizing Treatment in CIDP
Advancing ALS Through Gene Therapies, Early Intervention, and Multidisciplinary Care: Brian Lin, PhD
The Critical Role of Dystrophin in the Pathophysiology of Duchenne Muscular Dystrophy
Navigating Duchenne Muscular Dystrophy: An Early-Childhood Case Example
CSAI and INFUS-ON Study for Treatment of Parkinson Disease
Continuous Subcutaneous Apomorphine Infusion (CSAI) and TOLEDO Study in Parkinson Disease
Insights on Quanterix Simoa Assay to Diagnose Alzheimer Disease: Mark Roskey, PhD
A Mother’s Journey Through Diagnosis and Acceptance of Duchenne Muscular Dystrophy: Debra Miller
Related Content
